UCP2 and obesity disorder: Moreover, the promoter variant (−866G>A) has been associated with obesity and/or type 2 diabetes in several studies, with the A allele having greater UCP2 expression and lower glucose-stimulated insulin secretion (GSIS) than the G allele (87, 88, 363).